about
[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients.A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion.Assessment of metabolic activity by PET-CT with F-18-FDG in patients with T-cell lymphoma.Impact of ¹⁸F-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP.Fully automated synthesis procedure of 4-[18F]fluorobenzaldehyde by commercial synthesizer: amino-oxi peptide labelling prosthetic group.F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer.F-18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B-cell lymphoma.Palliative treatment of bone metastases with samarium-153 EDTMP at onset of painEnhancement of reaction conditions for the radiolabelling of DOTA-peptides with high activities of yttrium-90
P50
Q36490370-56022EE7-3225-4A15-BD18-F31EF551403EQ38823539-65C5CB9D-C4A4-481D-A4A9-FAA21497253AQ42927507-460BE743-5523-4668-ACE5-6FECCC7E5E8CQ43984265-F53DE9F0-6505-4FE4-8440-6CBD42BC0FB2Q46011581-9461E790-16AC-4FDC-A239-2292F25B6336Q48023043-E5B3B069-F6E2-4019-9A0E-820D32217618Q53083162-74094267-0E63-4EC4-8F63-31761763AFA4Q63243969-97C51B2C-01F0-42DA-85AD-6AD5F9588B86Q85091737-EC4277EA-F6F3-432E-BC48-2153C30169B2
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna Nardelli
@ast
Anna Nardelli
@en
Anna Nardelli
@es
Anna Nardelli
@nl
type
label
Anna Nardelli
@ast
Anna Nardelli
@en
Anna Nardelli
@es
Anna Nardelli
@nl
prefLabel
Anna Nardelli
@ast
Anna Nardelli
@en
Anna Nardelli
@es
Anna Nardelli
@nl
P106
P1153
56925008300
P21
P31
P496
0000-0003-4215-6022